Correlation Between MeVis Medical and Sabra Health

Can any of the company-specific risk be diversified away by investing in both MeVis Medical and Sabra Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MeVis Medical and Sabra Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MeVis Medical Solutions and Sabra Health Care, you can compare the effects of market volatilities on MeVis Medical and Sabra Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MeVis Medical with a short position of Sabra Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of MeVis Medical and Sabra Health.

Diversification Opportunities for MeVis Medical and Sabra Health

0.52

Correlation Coefficient

MeVis Medical  Sabra Health

Very weak diversification

The 3 months correlation between MeVis and Sabra is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding MeVis Medical Solutions and Sabra Health Care in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sabra Health Care and MeVis Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MeVis Medical Solutions are associated (or correlated) with Sabra Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sabra Health Care has no effect on the direction of MeVis Medical i.e., MeVis Medical and Sabra Health go up and down completely randomly.

Pair Corralation between MeVis Medical and Sabra Health

Assuming the 90 days trading horizon MeVis Medical Solutions is expected to generate 1.02 times more return on investment than Sabra Health. However, MeVis Medical is 1.02 times more volatile than Sabra Health Care. It trades about 0.16 of its potential returns per unit of risk. Sabra Health Care is currently generating about -0.17 per unit of risk. If you would invest  2,380  in MeVis Medical Solutions on September 17, 2024 and sell it today you would earn a total of  80.00  from holding MeVis Medical Solutions or generate 3.36% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

MeVis Medical Solutions  vs.  Sabra Health Care

MeVis Medical Solutions

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in MeVis Medical Solutions are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, MeVis Medical may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Sabra Health Care

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Sabra Health Care has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Sabra Health is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with MeVis Medical and Sabra Health

The main advantage of trading using opposite MeVis Medical and Sabra Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MeVis Medical position performs unexpectedly, Sabra Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sabra Health will offset losses from the drop in Sabra Health's long position.

The idea behind MeVis Medical Solutions and Sabra Health Care pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.